Standout Papers
Citation Impact
Citing Papers
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
Research issues in the study of difficult-to-treat depression
2003
Major Depressive Disorder
2000
Antidepressant Drug Effects and Depression Severity
2010 Standout
A Randomized Trial of rTMS Targeted with MRI Based Neuro-Navigation in Treatment-Resistant Depression
2009
Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [18F]-fluorodeoxyglucose PET and MRI study
2009
Neural systems approaches to understanding major depressive disorder: An intrinsic functional organization perspective
2012
Changes in Prefrontal Cortex and Paralimbic Activity in Depression Following Two Weeks of Daily Left Prefrontal TMS
1999
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
2003
Partial clinical response to 2 weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression
2008
Depression
2018 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management
2006
Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine
2006
Placebo Response in Studies of Major Depression
2002
No health without mental health
2007 Standout
Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder
2008
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Group Cognitive-Behavioral Therapy Versus Sertraline for the Treatment of Children and Adolescents With Obsessive-Compulsive Disorder
2005
Seasonal Affective Disorder: An Overview
2003
A Multifactorial Intervention to Reduce the Risk of Falling among Elderly People Living in the Community
1994 Standout
Psychological stress and incidence of ischaemic heart disease
1999
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
2005
Cannabinoid analgesia
2002
Adverse Health Effects of Marijuana Use
2014 Standout
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
Antecedent- and response-focused emotion regulation: Divergent consequences for experience, expression, and physiology.
1998 Standout
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
2006
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
2005
Meta-Analysis of Quantitative Sleep Parameters From Childhood to Old Age in Healthy Individuals: Developing Normative Sleep Values Across the Human Lifespan
2004 Standout
Distinct Regions of Prefrontal Cortex Mediate Resistance and Vulnerability to Depression
2008
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
2012 Standout
Measuring and manipulating brain connectivity with resting state functional connectivity magnetic resonance imaging (fcMRI) and transcranial magnetic stimulation (TMS)
2012
Child and adolescent mental health worldwide: evidence for action
2011 Standout
Suicide as an outcome for mental disorders
1997 Standout
The Drosophila Circadian Network Is a Seasonal Timer
2007 StandoutNobel
Cushing's syndrome
2015 Standout
The effect of sleep fragmentation on sleep and performance in younger and older subjects
1989
Sympathetic Nervous System Activity in Major Depression
1994
The Flinders Sensitive Line rat: A selectively bred putative animal model of depression
2005
Cannabinoids and cancer: causation, remediation, and palliation
2005
agriGO v2.0: a GO analysis toolkit for the agricultural community, 2017 update
2017 Standout
Clinical and Biochemical Manifestations of Depression
1988
Cannabinoid Transmission and Reward-Related Events
1998
Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew
2001
Brain stimulation for the treatment of psychiatric disorders
2007
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
2007
Molecular Clock Genes in Man and Lower Animals Possible Implications for Circadian Abnormalities in Depression
2000
Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression
2009
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
1998
Strange vision: ganglion cells as circadian photoreceptors
2003
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
2007
Caffeine induces central cholinergic analgesia
1997
Seasonal differences in the diurnal pattern of cortisol secretion in healthy participants and those with self-assessed seasonal affective disorder
2010
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Regional Cerebral Blood Flow Changes after Low-Frequency Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Treatment-Resistant Depression
2008
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
2013 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Circadian Clock-Related Polymorphisms in Seasonal Affective Disorder and their Relevance to Diurnal Preference
2002
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Cannabinoids and Multiple Sclerosis
2007
Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality
1989
Pharmacokinetics and Pharmacodynamics of Cannabinoids
2003
An analgesia circuit activated by cannabinoids
1998 Nature
Cannabinoids: potential anticancer agents
2003
Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation
2007
Sex differences in antidepressant efficacy
2018
Comparison of “standard” and “navigated” procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression
2010
Durability of antidepressant response to vagus nerve stimulation (VNS)
2007
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
2008
Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain
2003
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation?
2007
Major Depressive Disorder
2008 Standout
Depression and the Course of Coronary Artery Disease
1998
Neuroanatomical correlates of therapeutic efficacy of low‐frequency right prefrontal transcranial magnetic stimulation in treatment‐resistant depression
2011
The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories
1995 Standout
A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression
2007
Theta Burst Stimulation of the Prefrontal Cortex: Safety and Impact on Cognition, Mood, and Resting Electroencephalogram
2008
Cannabinoids in medicine: A review of their therapeutic potential
2006
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
2009
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
2009
Mortality in Danish psychiatric long‐stay patients, 1972–1982
1993
Clinical and Biochemical Manifestations of Depression
1988
rTMS of the Left Dorsolateral Prefrontal Cortex Modulates Dopamine Release in the Ipsilateral Anterior Cingulate Cortex and Orbitofrontal Cortex
2009
AKT/PKB Signaling: Navigating the Network
2017 Standout
Regulation of the Mammalian Circadian Clock by Cryptochrome
2004 StandoutNobel
GABAergic dysfunction in mood disorders
2003
Cannabinoids and multiple sclerosis
2002
Atherosclerosis
2000 StandoutNature
Rapid Reversal of Psychotic Depression Using Mifepristone
2001
Cannabis Use in HIV for Pain and Other Medical Symptoms
2005
Established and potential therapeutic applications of cannabinoids in oncology
2003
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 Standout
Coordination of circadian timing in mammals
2002 StandoutNature
The molecular neurobiology of depression
2008 StandoutNature
Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image‐guided neuronavigation
2010
Temperature as a dependent variable in the study of cholinergic mechanisms
1988
Sleep Disorders and Aging
1990
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
2004
An Ethics Perspective on Transcranial Magnetic Stimulation (TMS) and Human Neuromodulation
2006
Human Studies of Cannabinoids and Medicinal Cannabis
2005
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
2001
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
An open label trial of C-1073 (mifepristone) for psychotic major depression*
2002
The neurobiology of depression and antidepressant action
2012
Marijuana in the management of amyotrophic lateral sclerosis
2001
Cannabinoids and pain responses: a possible role for prostaglandins
1988
Disorders of Emotion
1991
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
2005
Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
2000
The Relationship of Anxiety and Depression: A Review of the Literature
1986
The prevalence of emotional and cognitive dysfunction in a general medical population: Using the MMSE, GHQ, and BDI
1983
Pharmacological interventions for somatoform disorders in adults
2014 Standout
An inventory for measuring clinical anxiety: Psychometric properties.
1988 Standout
Cannabis in painful HIV-associated sensory neuropathy
2007
Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students
2016 Standout
Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders
2006
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers
2007
Coil design considerations for deep-brain transcranial magnetic stimulation (dTMS)
2008
Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion
2001 Standout
Depression and mortality in a high-risk population
2002
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
2006
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
The circadian basis of winter depression
2006
Mortality in a Follow-up of 500 Psychiatric Outpatients
1985
The Antinociceptive Effects of Intrathecally Administered Levonantradol and Desacetyllevonantradol in the Rat
1981
Depression, Psychotropic Medication, and Risk of Myocardial Infarction
1996
Mortality of a Lithium-Treated Population
1984
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Cannabinoids in health and disease
2007
Neuroendocrine rhythms and sleep in aging men
1991
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
1988 Standout
Cannabinoid receptor localization in brain.
1990 Standout
Depression and mortality in a high-risk population
2002
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues
2004 Standout
Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.
2000
Cannabinoids for Medical Use
2015 Standout
Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer Chemotherapy
1979
Interindividual differences in the susceptibility of the cortisol system: An important factor for the degree of hypercortisolism in stress situations?
1987
A clinician's primer on the circadian clock: its localization, function, and resetting.
1993
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
1992 Standout
Diagnosing depression in the hospitalized medically ill
1983
Light Deprivation Induces Depression-Like Behavior and Suppresses Neurogenesis in Diurnal Mongolian Gerbil (Meriones unguiculatus)
2010
The relationship between anxiety and depression
1985
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Works of David Avery being referenced
The efficacy of electroconvulsive therapy and antidepressants in depression.
1977
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder
2010 Standout
A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression
2005
Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation
2004
Bright light therapy of subsyndromal
seasonal affective disorder in the workplace:
morning vs. afternoon exposure
2001
Dawn simulation compared with a dim red signal in the treatment of winter depression
1994
The analgesic effects of caffeine in headache
1991
A controlled study of dawn simulation in subsyndromal winter depression
1993
More Lateral and Anterior Prefrontal Coil Location Is Associated with Better Repetitive Transcranial Magnetic Stimulation Antidepressant Response
2009
Decreasing procedural pain over time of left prefrontal rtms for depression: Initial results from the open-label phase of a multisite trial (OPT-TMS)
2008
Bright dawn simulation compared with bright morning light in the treatment of winter depression
1992
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder
2008
Group and Individual Cognitive-Behavioral Therapy for Childhood Anxiety Disorders: A Randomized Trial
2002
Sleep is undisturbed in elderly, depressed individuals who have not sought health care
1990
Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression
1997
Dawn simulation and bright light in the treatment of SAD: a controlled study
2001
Depression Treated with Imipramine and ECT: The DeCarolis Study Reconsidered
1979
Circadian temperature rhythms in young adult and aged men
1986
Secondary depression in anxiety disorders
1981
REM latency and temperature in affective disorder before and after treatment.
1982
Chronicity of depressive episode in relation to antidepressant-placebo response.
1991
Adinazolam???A New Antidepressant
1987
The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder
1985
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
1975
REM latency and core temperature relationships in primary depression
1986
A Turning Point for Seasonal Affective Disorder and Light Therapy Research?
1998
rTMS studies of mood and emotion.
1999
Nocturnal temperature in affective disorder
1982
Gradual versus rapid dawn simulation treatment of winter depression.
1992
Body temperature and diurnal type in women with seasonal affective disorder
1993
Dawn simulation treatment of winter depression: a controlled study
1993
Mortality in Depressed Patients Treated With Electroconvulsive Therapy and Antidepressants
1976